MSD in the UK

MSD in the UK MSD’s official UK page. Intended for UK residents only. MSD respects the rights of individuals using social media to voice their views and opinions.

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd-uk.com and connect with us on Twitter, LinkedIn, Instagram, YouTube and Facebook. Community engagement guidelines

MSD’s social media channels offer a place for community members to learn about our corporate initiatives and programmes, including those in health and wellness, philanthropy and corporate responsibility. Providing useful and interesting content about our company and fostering open and respectful dialogue around specific topics is our ultimate goal. Healthcare is a regulated industry and, as such, we can't engage in discussions about our medicines and products or the products of other companies. However, within our social media channels, we reserve the right not to respond or to remove comments that are considered inappropriate, off-topic, abusive, or being used to solicit for third-party sites, initiatives or products. With this in mind, topic, abusive, or being used to promote and solicit for third we ask that you please respect the following guidelines for our feed:
•Please refrain from mentioning. MSD products or products from other companies, or from offering health or medical advice.
• Comments or posts that are factually inaccurate or misleading, include personal or graphic medical information, are spam or are soliciting business for MSD or for third party sites, initiatives or products, contain promotional material, are inappropriate, violate another’s copyright or intellectual property or individual are defamatory may be removed. Please note that the accounts that we follow, or are followed by, are not an indication endorsement by MSD or the content they produce. Comments made by third parties that mention , on feeds that follows, or on other platforms by third parties, do not necessarily represent the opinion of MSD or any of its alliance partners


Side effects or adverse events

If you believe that you, or another person, may have experienced side effects or reactions while taking an MSD product, you should immediately consult your physician, pharmacist or other healthcare professional. In order to monitor the safety of MSD products, should your comments mention an adverse event or side effect following or during the use of an MSD product, we encourage you to report this to MSD by calling us at 0208 154 8000, including outside of office hours or in an emergency, or by email at pv.uk@msd.com. ,

Furthermore, side effects or adverse events should additionally be reported to www.mhra.gov.uk/yellowcard. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or if you search for MHRA Yellow Card in the Google Play or Apple App Store. If you wish to report an adverse event or side effect, please provide the patient’s initials, age, date of birth and gender, your own details as the reporter, the name of the MSD product, and the specific details of the side effect or adverse effect experienced while using MSD product or the product quality complaint, including dates. Social media should not be used to report any side effects or reactions from an MSD product. We do not advise sharing personal health information on the Internet in any circumstances. Privacy

Any personal data provided by you will be treated by MSD with full respect of your privacy and you have the right to access your personal data. MSD will not share, use or store any personal information such as IDs or email addresses on social media without first obtaining appropriate consent, except for in the specific circumstances described in this policy, connected with adverse events, auditing, or third-party service providers

Any information you provide, including in the case of party service providers. an adverse event or product quality complaint, may be shared with regulatory agencies, our company subsidiaries, and business partners with whom we have contractual agreements. These individuals may be located in a country other than yours. In addition, we may be required to store personal information for the purpose of auditing. For more information about our company’s privacy commitment please visit: www.msdprivacy.com/uk

MSD may arrange for third-party service providers www.msdprivacy.com to assist with managing content and comments on social media. In such situations, these third-party providers will have access to information shared on our social media pages. All third-party providers will have access to all personal party service providers assisting MSD with its social media accounts will be bound by contractual terms imposing confidentiality and information security requirements to protect any personal identifying information shared on the page. MSD will retain your personal information for as long as required in order to fulfill any of the purposes described above. Location

Please keep in mind that our social media accounts are intended for UK audiences only.

Adults with Pulmonary Arterial Hypertension (PAH) – a subset of Pulmonary Hypertension (PH) – have a 50% survival rate j...
07/05/2025

Adults with Pulmonary Arterial Hypertension (PAH) – a subset of Pulmonary Hypertension (PH) – have a 50% survival rate just five years post-diagnosis.

This rare disease can often go undiagnosed for years due to its non-specific symptoms, like breathlessness.

That’s why on World PH Day, we reaffirmed our commitment to the PAH community and our hope to support them in overcoming the barriers they often face, such as delays in diagnosis.

Our analysis on the hidden costs of PAH diagnosis explores the economic burden of diagnosis, and the potential saving that could be achieved through the expedited diagnosis of PAH.

Read it here 👉: https://bit.ly/4jRop7k

GB-NON-11263

30/03/2025

We're celebrating Mother’s Day by recognising the commitment mothers make to their children, families and community around them—and reiterating our commitment to uplifting them each day.

To all amazing mothers and caregivers, we hope you have a wonderful Mother’s Day!

08/03/2025

Happy International Women’s Day! 🌟🎉

Today, and every day, we celebrate women whose hard work and achievements are paving the way for a future where every woman can shine

05/03/2025

Helping to promote global health by improving access to vaccines around the world is fundamental to our business and overall purpose: to save and improve lives 🌍

Rare Disease Day offers an opportunity to advocate for people affected by rare diseases such as Pulmonary Arterial Hyper...
28/02/2025

Rare Disease Day offers an opportunity to advocate for people affected by rare diseases such as Pulmonary Arterial Hypertension (PAH).

Our policy consensus statement on PAH is a beacon of our commitment to addressing the unique challenges faced by those living with this rare condition.

The policy consensus statement outlines a unified vision for the future of PAH care, created with input from the leading charity, PHA UK, and experts from Pulmonary Hypertension specialist centres from across the UK.

Learn more here: https://bit.ly/3QKi94x

24/12/2024

Merry Christmas and Happy Holidays from everyone at MSD! 🎄🔔

As the year comes to a close, we want to wish everyone a wonderful and restful holiday season. Our social media channels will be taking a short break ready to return on the 2nd January.

If you need us in the meantime, please find our contact details here: https://bit.ly/4guOhV5

05/05/2024

This World PH Day, we want to help spread knowledge and awareness of Pulmonary Arterial Hypertension (PAH), a subtype of Pulmonary Hypertension, or PH.

We’re committed to standing with the PAH community and want to shine a light on the signs and symptoms of this condition.

Take a moment to learn more.

GB-NON-09334

Address

120 Moorgate
London
EC2M6UR

Alerts

Be the first to know and let us send you an email when MSD in the UK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

#InventingForLife

Welcome to MSD’s official UK page. Intended for UK residents only. Posting about our commitment to #InventingForLife: www.msd-uk.com

Thank you for your interest in MSD. Please review our company’s social media policy before submitting any personal information to us.

Community engagement guidelines

MSD’s social media channels offer a place for community members to learn about our corporate initiatives and programmes, including those in health and wellness, philanthropy and corporate responsibility.